Multi Symptom Antacid

Description

QC(CDMA) Multi-Symptom Antacid Tablets are chewable tablets formulated to provide rapid relief from multiple gastrointestinal symptoms, including heartburn, gas pressure, bloating, discomfort, and acid indigestion. Each bottle contains 100 tablets, flavored with berry. The product is distributed by C.D.M.A., Inc., located at 41357 W. Nine Mile, Novi, MI 48376-0995. It is important to note that this product is not manufactured or distributed by Chattem Inc., the owner of the registered trademark ROLAIDS®. The packaging includes a tamper-evident seal; do not use if the printed inner seal is broken or missing. For inquiries, contact 248-449-9300 or visit www.qualitychoice.com.

Uses and Indications

This drug is indicated for the relief of heartburn, acid indigestion, and the pressure, bloating, and discomfort commonly referred to as gas.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Patients should chew 2 to 4 tablets completely as symptoms occur or as directed by a healthcare professional. It is important to follow the recommended dosage and not exceed the maximum dosage unless advised by a physician.

Contraindications

There are no specific contraindications identified for this product. However, it is essential to adhere to the following usage guidelines to ensure safety and efficacy:

• The maximum dosage should not exceed 8 tablets within a 24-hour period.

• The maximum dosage should not be used for more than 2 weeks.

Failure to comply with these recommendations may lead to potential adverse effects.

Warnings and Precautions

Healthcare professionals should be aware of the following warnings and precautions associated with the use of this medication.

It is imperative to consult a healthcare provider, such as a doctor or pharmacist, prior to use if the patient is currently taking any prescription medications. This is particularly important as antacids may interact with certain prescription drugs, potentially leading to adverse effects or reduced efficacy of the prescribed treatment.

In terms of general precautions, it is essential to adhere to the recommended dosage guidelines. Patients should not exceed 8 tablets within a 24-hour period. Furthermore, the maximum dosage should not be utilized for more than 2 weeks to avoid potential complications or side effects associated with prolonged use.

Currently, there are no specific laboratory tests recommended for monitoring the safe use of this medication. However, healthcare professionals should remain vigilant for any signs of adverse reactions or interactions, particularly in patients taking concurrent medications.

Side Effects

Patients should be advised to consult a doctor or pharmacist prior to using this product if they are currently taking any prescription medications, as antacids may interact with certain prescription drugs.

While using this product, it is important for patients to adhere to the recommended dosage guidelines. Specifically, patients should not exceed 8 tablets within a 24-hour period and should refrain from using the maximum dosage for more than 2 weeks.

Additionally, this product should be kept out of reach of children to prevent accidental ingestion.

Drug Interactions

Antacids may interact with various prescription medications, potentially affecting their absorption and efficacy. It is advisable to monitor the timing of antacid administration in relation to other medications to minimize these interactions. Specifically, antacids should be taken at least 2 hours apart from other drugs to ensure optimal therapeutic outcomes.

Packaging & NDC

Below are the non-prescription pack sizes of Multi Symptom Antacid (calcium carbonate, magnesium hydroxide, simethicone). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. The recommended dosage for children involves chewing 2-4 tablets completely as symptoms occur or as directed by a healthcare professional. It is important to note that pediatric patients should not exceed a maximum dosage of 8 tablets within a 24-hour period. Additionally, the maximum dosage should not be used for more than 2 weeks to ensure safety and efficacy.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

The available data does not indicate any specific warnings or precautions regarding the use of this product during pregnancy. There are no contraindications noted for pregnant patients, nor are there any identified risks to the fetus associated with its use. Additionally, the prescribing information does not recommend any dosage modifications or special precautions for individuals who are pregnant. Healthcare professionals should consider the absence of specific risk data when advising women of childbearing potential regarding the use of this product during pregnancy.

Lactation

There are no specific warnings or recommendations regarding the use of this product by lactating mothers. Additionally, there are no specific considerations or precautions mentioned related to lactation. Therefore, healthcare professionals may consider the use of this product in nursing mothers without specific concerns noted in the available data.

Renal Impairment

There is no specific information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of overdosage, it is critical to adhere to the recommended dosage guidelines to prevent adverse effects. The maximum allowable dosage is 8 tablets within a 24-hour period. Exceeding this limit may lead to serious health complications.

Healthcare professionals should be aware that the maximum dosage should not be utilized for more than 2 weeks. Prolonged use at this level increases the risk of toxicity and other associated health risks.

In cases of suspected overdosage, immediate medical attention is advised. Symptoms may vary depending on the specific circumstances and the individual’s health status. Management procedures should include supportive care and symptomatic treatment as necessary. Monitoring of the patient’s condition is essential to address any complications that may arise from the overdosage.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients not to exceed a maximum of 8 tablets within a 24-hour period. It is important to communicate that the maximum dosage should not be used for more than 2 weeks to avoid potential complications.

Additionally, patients should be encouraged to consult with their doctor or pharmacist prior to use if they are currently taking any prescription medications. This is particularly crucial as antacids may interact with certain prescription drugs, which could lead to adverse effects or reduced efficacy of the medications.

Storage and Handling

The product is supplied in a configuration that ensures tamper evidence; it should not be used if the printed inner seal is broken or missing.

For optimal storage, the product must be kept at a temperature range of 20-25°C (68-77°F). It is essential to avoid exposure to high humidity to maintain the integrity of the product.

Additional Clinical Information

The medication is administered orally, with patients instructed to chew 2-4 tablets completely as symptoms occur or as directed by a healthcare professional. There are no additional details available regarding laboratory tests, abuse information, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Multi Symptom Antacid, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)